+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Vaccines Market 2024-2028

  • PDF Icon

    Report

  • 163 Pages
  • March 2024
  • Region: Global
  • TechNavio
  • ID: 4855486
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The vaccines market is forecasted to grow by USD 56.39 bn during 2023-2028, accelerating at a CAGR of 13.83% during the forecast period. The report on the vaccines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased funding for vaccine development and new vaccine launches, need for novel vaccines for chronic infections, and increasing use of adjuvants in vaccines.

The vaccines market is segmented as below:

By Type

  • Human vaccine
  • Animal vaccine

By End-user

  • Hospitals
  • Clinics

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the development of nanoparticle vaccines as one of the prime reasons driving the vaccines market growth during the next few years. Also, increase in awareness of vaccine-preventable diseases among travelers and advancement in vaccine delivery system will lead to sizable demand in the market.

The report on the vaccines market covers the following areas:

  • Vaccines market sizing
  • Vaccines market forecast
  • Vaccines market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading vaccines market vendors that include Astellas Pharma Inc., Bavarian Nordic AS, Bharat Biotech Ltd., BrightPath Biotherapeutics Co. Ltd., CSL Ltd., Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Gradalis Inc., Inovio Pharmaceuticals Inc., Johnson and Johnson Services Inc., Merck KGaA, Mitsubishi Chemical Group Corp., Novavax Inc., Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., Takeda Pharmaceutical Co. Ltd., Valneva SE, and AstraZeneca PLC. Also, the vaccines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global vaccines market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global vaccines market 2018 - 2022 ($ billion)
4.2 Type Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
4.3 End-user Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type
6.1 Market segments
Exhibit 30: Chart on Type - Market share 2023-2028 (%)
Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Human vaccine - Market size and forecast 2023-2028
Exhibit 34: Chart on Human vaccine - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Human vaccine - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Human vaccine - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Human vaccine - Year-over-year growth 2023-2028 (%)
6.4 Animal vaccine - Market size and forecast 2023-2028
Exhibit 38: Chart on Animal vaccine - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Animal vaccine - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Animal vaccine - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Animal vaccine - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Type
Exhibit 42: Market opportunity by Type ($ billion)
Exhibit 43: Data Table on Market opportunity by Type ($ billion)
7 Market Segmentation by End-user
7.1 Market segments
Exhibit 44: Chart on End-user - Market share 2023-2028 (%)
Exhibit 45: Data Table on End-user - Market share 2023-2028 (%)
7.2 Comparison by End-user
Exhibit 46: Chart on Comparison by End-user
Exhibit 47: Data Table on Comparison by End-user
7.3 Hospitals - Market size and forecast 2023-2028
Exhibit 48: Chart on Hospitals - Market size and forecast 2023-2028 ($ billion)
Exhibit 49: Data Table on Hospitals - Market size and forecast 2023-2028 ($ billion)
Exhibit 50: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
7.4 Clinics - Market size and forecast 2023-2028
Exhibit 52: Chart on Clinics - Market size and forecast 2023-2028 ($ billion)
Exhibit 53: Data Table on Clinics - Market size and forecast 2023-2028 ($ billion)
Exhibit 54: Chart on Clinics - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Clinics - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by End-user
Exhibit 56: Market opportunity by End-user ($ billion)
Exhibit 57: Data Table on Market opportunity by End-user ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 UK - Market size and forecast 2023-2028
Exhibit 83: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 China - Market size and forecast 2023-2028
Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 99: Market opportunity By Geographical Landscape ($ billion)
Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 Astellas Pharma Inc.
Exhibit 107: Astellas Pharma Inc. - Overview
Exhibit 108: Astellas Pharma Inc. - Product/Service
Exhibit 109: Astellas Pharma Inc. - Key news
Exhibit 110: Astellas Pharma Inc. - Key offerings
12.4 AstraZeneca PLC
Exhibit 111: AstraZeneca PLC - Overview
Exhibit 112: AstraZeneca PLC - Product/Service
Exhibit 113: AstraZeneca PLC - Key news
Exhibit 114: AstraZeneca PLC - Key offerings
12.5 Bavarian Nordic AS
Exhibit 115: Bavarian Nordic AS - Overview
Exhibit 116: Bavarian Nordic AS - Product/Service
Exhibit 117: Bavarian Nordic AS - Key offerings
12.6 Bharat Biotech Ltd.
Exhibit 118: Bharat Biotech Ltd. - Overview
Exhibit 119: Bharat Biotech Ltd. - Product/Service
Exhibit 120: Bharat Biotech Ltd. - Key news
Exhibit 121: Bharat Biotech Ltd. - Key offerings
12.7 BrightPath Biotherapeutics Co. Ltd.
Exhibit 122: BrightPath Biotherapeutics Co. Ltd. - Overview
Exhibit 123: BrightPath Biotherapeutics Co. Ltd. - Product/Service
Exhibit 124: BrightPath Biotherapeutics Co. Ltd. - Key offerings
12.8 CSL Ltd.
Exhibit 125: CSL Ltd. - Overview
Exhibit 126: CSL Ltd. - Business segments
Exhibit 127: CSL Ltd. - Key offerings
Exhibit 128: CSL Ltd. - Segment focus
12.9 Daiichi Sankyo Co. Ltd.
Exhibit 129: Daiichi Sankyo Co. Ltd. - Overview
Exhibit 130: Daiichi Sankyo Co. Ltd. - Product/Service
Exhibit 131: Daiichi Sankyo Co. Ltd. - Key news
Exhibit 132: Daiichi Sankyo Co. Ltd. - Key offerings
12.10 Emergent BioSolutions Inc.
Exhibit 133: Emergent BioSolutions Inc. - Overview
Exhibit 134: Emergent BioSolutions Inc. - Product/Service
Exhibit 135: Emergent BioSolutions Inc. - Key news
Exhibit 136: Emergent BioSolutions Inc. - Key offerings
12.11 GlaxoSmithKline Plc
Exhibit 137: GlaxoSmithKline Plc - Overview
Exhibit 138: GlaxoSmithKline Plc - Business segments
Exhibit 139: GlaxoSmithKline Plc - Key news
Exhibit 140: GlaxoSmithKline Plc - Key offerings
Exhibit 141: GlaxoSmithKline Plc - Segment focus
12.12 Gradalis Inc.
Exhibit 142: Gradalis Inc. - Overview
Exhibit 143: Gradalis Inc. - Product/Service
Exhibit 144: Gradalis Inc. - Key offerings
12.13 Johnson and Johnson Services Inc.
Exhibit 145: Johnson and Johnson Services Inc. - Overview
Exhibit 146: Johnson and Johnson Services Inc. - Business segments
Exhibit 147: Johnson and Johnson Services Inc. - Key news
Exhibit 148: Johnson and Johnson Services Inc. - Key offerings
Exhibit 149: Johnson and Johnson Services Inc. - Segment focus
12.14 Merck KGaA
Exhibit 150: Merck KGaA - Overview
Exhibit 151: Merck KGaA - Business segments
Exhibit 152: Merck KGaA - Key news
Exhibit 153: Merck KGaA - Key offerings
Exhibit 154: Merck KGaA - Segment focus
12.15 Novavax Inc.
Exhibit 155: Novavax Inc. - Overview
Exhibit 156: Novavax Inc. - Product/Service
Exhibit 157: Novavax Inc. - Key offerings
12.16 Pfizer Inc.
Exhibit 158: Pfizer Inc. - Overview
Exhibit 159: Pfizer Inc. - Product/Service
Exhibit 160: Pfizer Inc. - Key news
Exhibit 161: Pfizer Inc. - Key offerings
12.17 Sanofi SA
Exhibit 162: Sanofi SA - Overview
Exhibit 163: Sanofi SA - Business segments
Exhibit 164: Sanofi SA - Key news
Exhibit 165: Sanofi SA - Key offerings
Exhibit 166: Sanofi SA - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 167: Inclusions checklist
Exhibit 168: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 169: Currency conversion rates for US$
13.4 Research methodology
Exhibit 170: Research methodology
Exhibit 171: Validation techniques employed for market sizing
Exhibit 172: Information sources
13.5 List of abbreviations
Exhibit 173: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Historic Market Size - Data Table on global vaccines market 2018 - 2022 ($ billion)
Exhibits 19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
Exhibits 20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Type - Market share 2023-2028 (%)
Exhibits 31: Data Table on Type - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Type
Exhibits 33: Data Table on Comparison by Type
Exhibits 34: Chart on Human vaccine - Market size and forecast 2023-2028 ($ billion)
Exhibits 35: Data Table on Human vaccine - Market size and forecast 2023-2028 ($ billion)
Exhibits 36: Chart on Human vaccine - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Human vaccine - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Animal vaccine - Market size and forecast 2023-2028 ($ billion)
Exhibits 39: Data Table on Animal vaccine - Market size and forecast 2023-2028 ($ billion)
Exhibits 40: Chart on Animal vaccine - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Animal vaccine - Year-over-year growth 2023-2028 (%)
Exhibits 42: Market opportunity by Type ($ billion)
Exhibits 43: Data Table on Market opportunity by Type ($ billion)
Exhibits 44: Chart on End-user - Market share 2023-2028 (%)
Exhibits 45: Data Table on End-user - Market share 2023-2028 (%)
Exhibits 46: Chart on Comparison by End-user
Exhibits 47: Data Table on Comparison by End-user
Exhibits 48: Chart on Hospitals - Market size and forecast 2023-2028 ($ billion)
Exhibits 49: Data Table on Hospitals - Market size and forecast 2023-2028 ($ billion)
Exhibits 50: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits 51: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits 52: Chart on Clinics - Market size and forecast 2023-2028 ($ billion)
Exhibits 53: Data Table on Clinics - Market size and forecast 2023-2028 ($ billion)
Exhibits 54: Chart on Clinics - Year-over-year growth 2023-2028 (%)
Exhibits 55: Data Table on Clinics - Year-over-year growth 2023-2028 (%)
Exhibits 56: Market opportunity by End-user ($ billion)
Exhibits 57: Data Table on Market opportunity by End-user ($ billion)
Exhibits 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 61: Chart on Geographic comparison
Exhibits 62: Data Table on Geographic comparison
Exhibits 63: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 64: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 67: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 68: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 71: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 72: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 79: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 80: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 82: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 83: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits 84: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits 85: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 86: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits 88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 91: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits 92: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits 93: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 95: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits 96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits 97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits 98: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits 99: Market opportunity By Geographical Landscape ($ billion)
Exhibits 100: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits 101: Impact of drivers and challenges in 2023 and 2028
Exhibits 102: Overview on Criticality of inputs and Factors of differentiation
Exhibits 103: Overview on factors of disruption
Exhibits 104: Impact of key risks on business
Exhibits 105: Vendors covered
Exhibits 106: Matrix on vendor position and classification
Exhibits 107: Astellas Pharma Inc. - Overview
Exhibits 108: Astellas Pharma Inc. - Product/Service
Exhibits 109: Astellas Pharma Inc. - Key news
Exhibits 110: Astellas Pharma Inc. - Key offerings
Exhibits 111: AstraZeneca PLC - Overview
Exhibits 112: AstraZeneca PLC - Product/Service
Exhibits 113: AstraZeneca PLC - Key news
Exhibits 114: AstraZeneca PLC - Key offerings
Exhibits 115: Bavarian Nordic AS - Overview
Exhibits 116: Bavarian Nordic AS - Product/Service
Exhibits 117: Bavarian Nordic AS - Key offerings
Exhibits 118: Bharat Biotech Ltd. - Overview
Exhibits 119: Bharat Biotech Ltd. - Product/Service
Exhibits 120: Bharat Biotech Ltd. - Key news
Exhibits 121: Bharat Biotech Ltd. - Key offerings
Exhibits 122: BrightPath Biotherapeutics Co. Ltd. - Overview
Exhibits 123: BrightPath Biotherapeutics Co. Ltd. - Product/Service
Exhibits 124: BrightPath Biotherapeutics Co. Ltd. - Key offerings
Exhibits 125: CSL Ltd. - Overview
Exhibits 126: CSL Ltd. - Business segments
Exhibits 127: CSL Ltd. - Key offerings
Exhibits 128: CSL Ltd. - Segment focus
Exhibits 129: Daiichi Sankyo Co. Ltd. - Overview
Exhibits 130: Daiichi Sankyo Co. Ltd. - Product/Service
Exhibits 131: Daiichi Sankyo Co. Ltd. - Key news
Exhibits 132: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits 133: Emergent BioSolutions Inc. - Overview
Exhibits 134: Emergent BioSolutions Inc. - Product/Service
Exhibits 135: Emergent BioSolutions Inc. - Key news
Exhibits 136: Emergent BioSolutions Inc. - Key offerings
Exhibits 137: GlaxoSmithKline Plc - Overview
Exhibits 138: GlaxoSmithKline Plc - Business segments
Exhibits 139: GlaxoSmithKline Plc - Key news
Exhibits 140: GlaxoSmithKline Plc - Key offerings
Exhibits 141: GlaxoSmithKline Plc - Segment focus
Exhibits 142: Gradalis Inc. - Overview
Exhibits 143: Gradalis Inc. - Product/Service
Exhibits 144: Gradalis Inc. - Key offerings
Exhibits 145: Johnson and Johnson Services Inc. - Overview
Exhibits 146: Johnson and Johnson Services Inc. - Business segments
Exhibits 147: Johnson and Johnson Services Inc. - Key news
Exhibits 148: Johnson and Johnson Services Inc. - Key offerings
Exhibits 149: Johnson and Johnson Services Inc. - Segment focus
Exhibits 150: Merck KGaA - Overview
Exhibits 151: Merck KGaA - Business segments
Exhibits 152: Merck KGaA - Key news
Exhibits 153: Merck KGaA - Key offerings
Exhibits 154: Merck KGaA - Segment focus
Exhibits 155: Novavax Inc. - Overview
Exhibits 156: Novavax Inc. - Product/Service
Exhibits 157: Novavax Inc. - Key offerings
Exhibits 158: Pfizer Inc. - Overview
Exhibits 159: Pfizer Inc. - Product/Service
Exhibits 160: Pfizer Inc. - Key news
Exhibits 161: Pfizer Inc. - Key offerings
Exhibits 162: Sanofi SA - Overview
Exhibits 163: Sanofi SA - Business segments
Exhibits 164: Sanofi SA - Key news
Exhibits 165: Sanofi SA - Key offerings
Exhibits 166: Sanofi SA - Segment focus
Exhibits 167: Inclusions checklist
Exhibits 168: Exclusions checklist
Exhibits 169: Currency conversion rates for US$
Exhibits 170: Research methodology
Exhibits 171: Validation techniques employed for market sizing
Exhibits 172: Information sources
Exhibits 173: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global vaccines market: Astellas Pharma Inc., Bavarian Nordic AS, Bharat Biotech Ltd., BrightPath Biotherapeutics Co. Ltd., CSL Ltd., Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Gradalis Inc., Inovio Pharmaceuticals Inc., Johnson and Johnson Services Inc., Merck KGaA, Mitsubishi Chemical Group Corp., Novavax Inc., Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., Takeda Pharmaceutical Co. Ltd., Valneva SE, and AstraZeneca PLC.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is development of nanoparticle vaccines.'

According to the report, one of the major drivers for this market is the increased funding for vaccine development and new vaccine launches.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Astellas Pharma Inc.
  • Bavarian Nordic AS
  • Bharat Biotech Ltd.
  • BrightPath Biotherapeutics Co. Ltd.
  • CSL Ltd.
  • Daiichi Sankyo Co. Ltd.
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline Plc
  • Gradalis Inc.
  • Inovio Pharmaceuticals Inc.
  • Johnson and Johnson Services Inc.
  • Merck KGaA
  • Mitsubishi Chemical Group Corp.
  • Novavax Inc.
  • Pfizer Inc.
  • Sanofi SA
  • Serum Institute of India Pvt. Ltd.
  • Takeda Pharmaceutical Co. Ltd.
  • Valneva SE
  • AstraZeneca PLC